Sharp Therapeutics Announces Closing of Fourth Tranche of Unsecured Convertible Note Offering

Apr 10, 2026 | Press Releases

Pittsburgh, Pennsylvania and Toronto, Ontario–(Newsfile Corp. – April 10, 2026) – Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) (“Sharp” or the “Company”) is pleased to announce that it has closed the fourth tranche...

Sharp Therapeutics Announces Closing of Third Tranche of Unsecured Convertible Note Offering

Apr 2, 2026 | Press Releases

Pittsburgh, Pennsylvania and Toronto, Ontario–(Newsfile Corp. – April 2, 2026) – Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) (“Sharp” or the “Company”) is pleased to announce that it has closed the third tranche (the...

Sharp Therapeutics Announces Closing of Second Tranche of Unsecured Convertible Note Offering

Mar 13, 2026 | Press Releases

Pittsburgh, Pennsylvania and Toronto, Ontario–(Newsfile Corp. – March 13, 2026) – Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) (“Sharp” or the “Company”) is pleased to announce that it has closed the second tranche...

Sharp Therapeutics Announces Closing of First Tranche of Unsecured Convertible Note Offering

Feb 27, 2026 | Press Releases

Pittsburgh, Pennsylvania and Toronto, Ontario–(Newsfile Corp. – February 27, 2026) – Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) (“Sharp” or the “Company”) is pleased to announce that it has closed the first tranche...

Sharp Therapeutics Announces Private Placement of up to US$3.0 Million in Unsecured Convertible Notes

Feb 2, 2026 | Press Releases

Pittsburgh, Pennsylvania and Toronto, Ontario–(Newsfile Corp. – February 2, 2026) – Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) (“Sharp” or the “Company”) is pleased to announce the terms of a proposed non-brokered...